CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome

Fertil Steril. 2009 Aug;92(2):653-9. doi: 10.1016/j.fertnstert.2008.07.016. Epub 2008 Aug 23.

Abstract

Objective: To analyze promoter regions of CYP11A1 and CYP17 for putative variations in a defined group of women with polycystic ovary syndrome (PCOS) and to study their association with androgen levels.

Design: Retrospective study.

Setting: A secondary referral center for infertility at National Institute for Research in Reproductive Health, Mumbai, India.

Patient(s): One hundred women whose condition was diagnosed on the basis of the Rotterdam consensus were compared against 100 age-matched controls.

Intervention(s): A single sample of blood was collected after overnight fast on day 3 of the menstrual cycle.

Main outcome measure(s): Plasma levels of T, androstenedione, 17alpha-hydroxyprogesterone, and DHEAS and nucleotide sequence of promoter regions of CYP11A1 and CYP17 genes.

Result(s): Polymorphisms in promoter regions of the two key androgen-regulating genes, CYP11A1 and CYP17, were found to be significantly associated with T levels in the cohort of well-characterized PCOS cases as compared with controls. The significance was greater in the PCOS cases with both the polymorphisms.

Conclusion(s): Our study carried out in a defined group of Indian women with PCOS suggests for the first time an individual, as well as combined, association of polymorphisms in CYP11A1 and CYP17 promoters with T levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholesterol Side-Chain Cleavage Enzyme / genetics*
  • Comorbidity
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Hydroxysteroid Dehydrogenases / genetics*
  • Hyperandrogenism / epidemiology*
  • Hyperandrogenism / genetics*
  • Incidence
  • India / epidemiology
  • Polycystic Ovary Syndrome / epidemiology*
  • Polycystic Ovary Syndrome / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Promoter Regions, Genetic / genetics
  • Risk Assessment
  • Risk Factors
  • Steroid 17-alpha-Hydroxylase / genetics*
  • Young Adult

Substances

  • Hydroxysteroid Dehydrogenases
  • 3(17)-hydroxysteroid dehydrogenase
  • Steroid 17-alpha-Hydroxylase
  • Cholesterol Side-Chain Cleavage Enzyme